Mirum Pharmaceuticals's market cap is currently $2.55B. The company's EPS TTM is $-2.067; its P/E ratio is ―; Mirum Pharmaceuticals is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 186.37M	$ 77.06M	$ 19.14M	$ 0.00	$ 0.00
Gross Profit	$ 139.34M	$ 64.69M	$ 17.23M	$ -623.00K	$ -324.00K
Operating Income	$ -109.15M	$ -131.22M	$ -173.41M	$ -104.30M	$ -54.74M
EBITDA	$ -136.49M	$ -122.41M	$ -65.39M	$ -102.31M	$ -52.21M
Net Income	$ -163.41M	$ -135.66M	$ -83.99M	$ -103.27M	$ -52.55M
Balance Sheet
Cash & Short-Term Investments	$ 286.33M	$ 251.72M	$ 156.54M	$ 231.82M	$ 139.95M
Total Assets	$ 646.62M	$ 352.91M	$ 294.65M	$ 240.86M	$ 146.71M
Total Debt	$ 308.14M	$ 2.19M	$ 2.61M	$ 3.26M	$ 3.65M
Net Debt	$ 21.82M	$ -25.82M	$ -28.73M	$ -138.82M	$ -136.30M
Total Liabilities	$ 397.95M	$ 210.87M	$ 174.44M	$ 68.77M	$ 16.36M
Stockholders' Equity	$ 248.67M	$ -392.82M	$ 120.21M	$ -173.17M	$ -69.90M
Cash Flow
Free Cash Flow	$ -91.05M	$ -120.41M	$ -151.78M	$ -89.30M	$ -39.64M
Operating Cash Flow	$ -70.94M	$ -120.14M	$ -132.76M	$ -89.08M	$ -39.36M
Investing Cash Flow	$ -107.20M	$ 7.70M	$ 48.55M	$ 37.87M	$ -127.78M
Financing Cash Flow	$ 336.60M	$ 109.09M	$ 73.47M	$ 181.29M	$ 127.18M

Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History

Income Statement >

Mirum Pharmaceuticals Debt to Assets

Balance Sheet >

Mirum Pharmaceuticals Cash Flow

Cash Flow >

Mirum Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing